Published May 19, 2023

E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more

This episode explores Sam Altman's strategic navigation of AI regulation, likening its risks to nuclear technology, amid a tech landscape reshaped by Apple's AR innovation and the open-source AI movement. Additionally, it delves into San Francisco's real estate woes and the impact of regulatory battles in the pharmaceutical industry, emphasizing the intersection of technology, regulation, and market forces.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

E124: AutoGPT's massive potential and risk, AI regulation, Bob Lee/SF update
Answers 383 questions
E171: DOJ sues Apple, AI arms race, Reddit IPO, Realtor settlement & more
Answers 383 questions
E157: Epic legal win, OpenAI's news deal, FCC targets Elon, the limits of free speech & more
Answers 383 questions
E122: Is AI the next great computing platform? ChatGPT vs. Google, containing AGI & RESTRICT Act
Answers 383 questions
E168: Can Google save itself? Abolish HR, AI takes over Customer Support, Reddit IPO teardown
Answers 383 questions
E133: Market melt-up, IPO update, AI startups overheat, Reddit revolts & more with Brad Gerstner
Answers 383 questions
E128: Google enters AI wars, Druck’s warning, Trump crushes CNN & more
Answers 383 questions
DOJ targets Nvidia, Meme stock comeback, Trump fundraiser in SF, Apple/OpenAI, Texas stock market
Answers 383 questions
E115: The AI Search Wars: Google vs. Microsoft, Nordstream report, State of the Union
Answers 383 questions
E135: Wagner rebels, SCOTUS ends AA, AI M&A, startups gone bad, spacetime warps & more
Answers 383 questions
New SEC Chair, Bitcoin, xAI Supercomputer, UnitedHealth CEO murder, with Gavin Baker & Joe Lonsdale
Answers 383 questions
E169: Elon sues OpenAI, Apple's decline, TikTok ban, Bitcoin $100K?, Science corner: Microplastics
Answers 383 questions
E167: Google's Woke AI disaster, Nvidia smashes earnings (again), Groq's LPU breakthrough & more
Answers 383 questions
E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Answers 383 questions
E13: SPACsgiving Special! Vaccine news, innovation vs regulation, fixing higher ed, challenge trials
Answers 383 questions

Dexa/All-In Podcast

E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more

Topics covered

Popular Clips

Regulating Big Tech

Regulating AI Models

Biotech Investment Dynamics

Legal Consequences Explored

Apple's AR Headset

Real Estate Insights

AI and Existential Risks

Mental Health Solutions

Open Source Revolution

AI Models Explained

Amgen's Acquisition Debate

AR Innovation Insights

Lawlessness and Vigilantism

Twitter's New CEO

Episode Highlights

AI Regulation Debate

Tech Industry Dynamics

City Real Estate Challenges

Big Pharma and Regulation

Related Episodes

E124: AutoGPT's massive potential and risk, AI regulation, Bob Lee/SF update

E171: DOJ sues Apple, AI arms race, Reddit IPO, Realtor settlement & more

E157: Epic legal win, OpenAI's news deal, FCC targets Elon, the limits of free speech & more

E122: Is AI the next great computing platform? ChatGPT vs. Google, containing AGI & RESTRICT Act

E168: Can Google save itself? Abolish HR, AI takes over Customer Support, Reddit IPO teardown

E133: Market melt-up, IPO update, AI startups overheat, Reddit revolts & more with Brad Gerstner

E128: Google enters AI wars, Druck’s warning, Trump crushes CNN & more

DOJ targets Nvidia, Meme stock comeback, Trump fundraiser in SF, Apple/OpenAI, Texas stock market

E115: The AI Search Wars: Google vs. Microsoft, Nordstream report, State of the Union

E135: Wagner rebels, SCOTUS ends AA, AI M&A, startups gone bad, spacetime warps & more

New SEC Chair, Bitcoin, xAI Supercomputer, UnitedHealth CEO murder, with Gavin Baker & Joe Lonsdale

E169: Elon sues OpenAI, Apple's decline, TikTok ban, Bitcoin $100K?, Science corner: Microplastics

E167: Google's Woke AI disaster, Nvidia smashes earnings (again), Groq's LPU breakthrough & more

E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more

E13: SPACsgiving Special! Vaccine news, innovation vs regulation, fixing higher ed, challenge trials

E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more

Topics covered

Popular Clips

Episode Highlights

AI Regulation DebateSam Altman navigates the complexities of AI regulation, proposing a new agency to oversee its development. The discussion highlights the potential for regulatory capture and the existential risks associated with AI, drawing parallels to nuclear technology.

AI Regulation Debate

Tech Industry DynamicsApple's AR headset is set to redefine the tech landscape with its innovative approach, while the open-source AI movement challenges traditional regulatory frameworks. These developments highlight the dynamic interplay between technology advancement and market competition.

Tech Industry Dynamics

City Real Estate ChallengesSan Francisco's real estate market is grappling with high vacancy rates and potential banking issues, while the broader housing market faces a freeze due to unaffordable mortgages and declining consumer confidence.

City Real Estate Challenges

Big Pharma and Regulation

Related Episodes